Nuvation Bio, Inc. (NUVB)
5.79
+0.07
(+1.22%)
USD |
NYSE |
Feb 12, 16:00
5.80
+0.01
(+0.17%)
After-Hours: 20:00
Nuvation Bio EPS Diluted (Quarterly) : -0.163 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1621 |
| Indivior Pharmaceuticals, Inc. | 0.3256 |
| Terns Pharmaceuticals, Inc. | -0.2686 |
| GRAIL, Inc. | -2.463 |
| Arrowhead Pharmaceuticals, Inc. | 0.219 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -55.79M |
| Revenue (Quarterly) | 13.12M |
| Total Expenses (Quarterly) | 68.91M |
| Enterprise Value | 1.620B |
| Gross Profit Margin (Quarterly) | 70.40% |
| Profit Margin (Quarterly) | -425.2% |
| Earnings Yield | -11.06% |
| Normalized Earnings Yield | -11.02 |